Article
Mesenchymal stem cell derived proteome can target multiple signalling pathways to ameliorate rheumatoid arthritis: network pharmacology and molecular docking based approach
2024-04-10
Abstract excerpt
<title>Abstract</title> <p>Rheumatoid arthritis (RA) is an autoimmune chronic inflammatory disease with a global prevalence of approximately 1%. Mesenchymal stem cells (MSCs) have been thoroughly investigated for the treatment of RA; however, their clinical use is limited due to issues related to cell engraftment. It is now well established that MSCs exert their regenerative effect through the paracrine mechanism...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1c983934-c996-5bde-bb8e-283062ced35c
- DOI
- 10.21203/rs.3.rs-4182815/v1
